GlassScriptPhysician profile
Joseph Daniel Pennington
NPI 1356608434
$6,042.56
in general payments reported to CMS, 2019-2025
29 companies · $860 in 2025
The $860 reported for 2025 was more than what 81% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $2,107 · 2021: $928 · 2022: $676 · 2023: $352 · 2024: $414 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215 · Travel and Lodging: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.17 |
| Travel and Lodging | $409.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,920.00 | 2020 | |
| Blue Earth Diagnostics | $1,110.49 | 2021-2025 | Posluma |
| Teleflex LLC | $627.21 | 2023-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $265.36 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Brainlab, INC. | $234.16 | 2019 | |
| Dendreon Pharmaceuticals LLC | $219.60 | 2019-2024 | Provenge |
| Palette Life Sciences, INC. | $186.00 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $180.12 | 2022-2024 | Pylarify |
| Isoray, INC | $161.97 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.36 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $117.47 | 2025 | Varian Ethos Treatment Planning, Aria Radiation Therapy Management Software, Eclipse Treatment Planning System For External Beam Radiation Therapy |
| Astrazeneca Pharmaceuticals LP | $114.58 | 2019-2024 | |
| Antares Pharma, INC. | $99.17 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $90.43 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $70.60 | 2019-2024 | Xiaflex |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Accelerator Applications | $67.54 | 2019 | |
| Urogen Pharma, INC. | $58.82 | 2020-2023 | Jelmyto |
| Tempus Ai, INC | $54.99 | 2024-2025 | Xt Cdx |
| Urovant Sciences INC | $52.50 | 2022 | |
| Merck Sharp & Dohme LLC | $52.33 | 2024-2025 | Lynparza, Keytruda Qlex, Welireg |
| Novocure INC. | $46.21 | 2023-2024 | Optune Lua (Novottf-200t), Optune |
| Sun Pharmaceutical Industries INC. | $35.23 | 2019-2020 | |
| Myovant Sciences INC. | $24.27 | 2021 | |
| Neotract INC. | $23.64 | 2020 | |
| Accord Healthcare, INC. | $21.36 | 2023 | |
| Pfizer INC. | $19.58 | 2025 | |
| Bard Peripheral Vascular, INC. | $19.02 | 2022 | |
| Varian Medical Systems, INC. | $16.82 | 2020 | |
| Amgen INC. | $15.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.